These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1588270)

  • 21. Insulin sensitivity and cardiovascular risk factors in hypertensive and normotensive native Ghanaians.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Diabetologia; 2003 Jul; 46(7):949-55. PubMed ID: 12819902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism.
    Peacock M; Bilezikian JP; Klassen PS; Guo MD; Turner SA; Shoback D
    J Clin Endocrinol Metab; 2005 Jan; 90(1):135-41. PubMed ID: 15522938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia.
    Joborn C; Hetta J; Lind L; Rastad J; Akerström G; Ljunghall S
    Surgery; 1989 Jan; 105(1):72-8. PubMed ID: 2911806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.
    Savage PJ; Pressel SL; Curb JD; Schron EB; Applegate WB; Black HR; Cohen J; Davis BR; Frost P; Smith W; Gonzalez N; Guthrie GP; Oberman A; Rutan G; Probstfield JL; Stamler J
    Arch Intern Med; 1998 Apr; 158(7):741-51. PubMed ID: 9554680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans.
    Fliser D; Franek E; Fode P; Stefanski A; Schmitt CP; Lyons M; Ritz E
    Nephrol Dial Transplant; 1997 May; 12(5):933-8. PubMed ID: 9175045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the treatment efficacy of secondary hyperparathyroidism with oral pulse doses of alphacalcidol].
    Switalski M; Kuriga M; Wańkowicz Z
    Pol Arch Med Wewn; 1997 Oct; 98(10):358-65. PubMed ID: 9557090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenomedullin concentrations are elevated in plasma of patients with primary hyperparathyroidism.
    Letizia C; Caliumi C; Delfini E; Celi M; Subioli S; Diacinti D; Minisola S; D'erasmo E; Mazzuoli GF
    Metabolism; 2003 Feb; 52(2):159-62. PubMed ID: 12601625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminopropylidine diphosphonate (APD) in mild primary hyperparathyroidism: effect on clinical status.
    Schmidli RS; Wilson I; Espiner EA; Richards AM; Donald RA
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):293-300. PubMed ID: 2188763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis.
    Brandi L; Daugaard H; Tvedegaard E; Storm T; Olgaard K
    Nephron; 1989; 53(3):194-200. PubMed ID: 2797340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term treatment with large doses of alphacalicidol in secondary hyperparathyroidism of patients dialyzed for end stage renal failure].
    Matuszkiewicz-Rowińska J; Niemczyk S; Pacocha E; Puka J; Switalski M; Bogdańska-Straszyńska B; Ostrowski K
    Pol Arch Med Wewn; 1996 Jul; 96(1):15-22. PubMed ID: 8966141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure.
    Raine AE; Bedford L; Simpson AW; Ashley CC; Brown R; Woodhead JS; Ledingham JG
    Kidney Int; 1993 Mar; 43(3):700-5. PubMed ID: 8455369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-Alpha-hydroxy vitamin D3 in primary hyperparathyroidism.
    Boyle IT; Fogelman I; Beastall GH; Joffe S; Boyce B
    Br Med J; 1979 Mar; 1(6166):822-3. PubMed ID: 435823
    [No Abstract]   [Full Text] [Related]  

  • 33. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind, placebo-controlled study of ramipril in diabetics with mild to moderate hypertension.
    Schwartz SL; Hanson C; Lucas C; Rosenblatt S; Rosenstock J; Whittier F; Wistran D; Riche C; Mulcahy WS
    Clin Ther; 1993; 15(1):79-87. PubMed ID: 8458057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of hyperparathyroidism in patients on maintenance dialysis by intravenous 1-alpha-hydroxyvitamin D3 in association with Mg(OH)2 as sole phosphate binder. A randomized comparative study with the association CaCO3 +/- Mg(OH)2.
    Mornière P; Maurouard C; Boudailliez B; Westeel PF; Achard JM; Boitte F; el Esper N; Compagnon M; Maurel G; Bouillon R
    Nephron; 1992; 60(2):154-63. PubMed ID: 1552999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fasting insulin, calcium metabolism and the electrocardiogram in hypertensive subjects.
    Lind L; Hvarfner A; Pollare T; Lithell H; Ljunghall S
    J Intern Med; 1992 Oct; 232(4):335-9. PubMed ID: 1402637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The conservative management of primary hyperparathyroidism.
    Sampson MJ; van't Hoff W; Bicknell EJ
    Q J Med; 1987 Dec; 65(248):1009-14. PubMed ID: 3455552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
    Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
    Widimský J; Sirotiaková J
    Curr Med Res Opin; 2006 Jul; 22(7):1287-94. PubMed ID: 16834827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.
    Woodman RJ; Mori TA; Burke V; Puddey IB; Watts GF; Beilin LJ
    Am J Clin Nutr; 2002 Nov; 76(5):1007-15. PubMed ID: 12399272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.